Nemaura Medical Inc. (NMRD) |
|
2.57 -0.01 (-0.39%)
|
07-02 20:31 |
|
Open: |
2.52 |
Pre. Close: |
2.58 |
|
High:
|
2.57 |
Low:
|
2.52 |
|
Volume:
|
3,093 |
Market Cap:
|
62(M) |
|
|
|
|
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.57 - 2.59 |
2.59 - 2.6 |
|
Low:
|
2.48 - 2.5 |
2.5 - 2.52 |
|
Close:
|
2.54 - 2.57 |
2.57 - 2.59 |
|
Technical analysis |
as of: 2022-07-01 4:23:58 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 3.28  One year: 3.5 |
| Support: |
Support1: 2.51 Support2: 2.09 |
| Resistance: |
Resistance1: 2.81 Resistance2: 3 |
| Pivot: |
2.66 |
| Moving Average: |
MA(5): 2.64 MA(20): 2.7
MA(100): 3.5 MA(250): 4.88 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1  |
| Stochastic oscillator: |
%K(14,3): 8.9 %D(3): 15.1 |
| RSI: |
RSI(14): 41.2 |
| 52-week: |
High: 9.68 Low: 2.15 |
| Average Vol(K): |
3-Month: 6 (K) 10-Days: 4 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NMRD ] has closed above bottom band by 21.2%. Bollinger Bands are 54.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Thu, 30 Jun 2022
Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022 - Yahoo Finance
Wed, 22 Jun 2022
Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding - GuruFocus.com
Thu, 19 May 2022
Nemaura Medical to Present at the HC Wainwright Global Hybrid Investment Conference - GlobeNewswire
Tue, 03 May 2022
MySugarWatch Launches Physician-Focused Ads in MIMS As Part of Large-Scale Awareness Campaign Around Nemaura Medical’s sugarBEAT Non-Invasive Continuous Glucose Monitor - Yahoo Finance
Thu, 10 Mar 2022
Nemaura Medical: Opportunity In The Continuous Glucose Monitoring Market - Seeking Alpha
Mon, 28 Feb 2022
Nemaura Medical Wins Innovation Awards - GlobeNewswire
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
0 (M) |
| Shares Float |
23 (M) |
|
% Held by Insiders
|
9.93e+006 (%) |
|
% Held by Institutions
|
58.7 (%) |
|
Shares Short
|
166 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-6.34e+006 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-3 |
|
Return on Assets (ttm)
|
543.7 |
|
Return on Equity (ttm)
|
-18.2 |
|
Qtrly Rev. Growth
|
183630 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
-0.25 |
|
Qtrly Earnings Growth
|
-0.5 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-6 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
-0.14 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
139970 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2019-12-04 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
